Page last updated: 2024-08-24

gemcitabine and Leiomyosarcoma

gemcitabine has been researched along with Leiomyosarcoma in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	22 (33.33)	29.6817
2010's	37 (56.06)	24.3611
2020's	7 (10.61)	2.80

Authors

Authors	Studies
Ahn, JH; Baek, W; Han, YD; Jung, I; Kim, CG; Kim, HS; Kim, JE; Kim, JH; Kim, SH; Kim, SK; Koh, YW; Lee, YH; Rha, SY; Shin, SJ; Sim, NS; Yun, KH	1
Blanco-Alcaina, E; Castilla, C; González-Aguilera, C; Hindi, N; López-Álvarez, M; Martín-Broto, J; Martín-Ruiz, M; Mondaza-Hernández, JL; Moura, DS; Ramos, R; Renshaw, M; Sánchez-Bustos, P	1
Hosseinifard, H; Hua, Z; Ijaz, I; Imani, S; Kahloon, LE; Liu, S; Sefidan, MO; Shahzad, MN; Zhang, YQ	1
Bay, JO; Bertucci, F; Bompas, E; Bozec, L; Chenuc, G; Chevreau, C; Cupissol, D; Delaye, J; Delcambre, C; Duffaud, F; Eymard, JC; Guillemet, C; Isambert, N; Italiano, A; Pautier, P; Penel, N; Piperno-Neumann, S; Ray-Coquard, I; Rios, M; Saada, E	1
Harano, K; Motohashi, T; Nakanishi, T; Saito, T; Susumu, N; Takehara, K; Teramoto, N; Tokunaga, H; Tsuda, H; Ueda, Y; Watanabe, R; Yamashita, N; Yokoyama, Y	1
Hata, M; Kawana, K; Maebayashi, A; Nagaishi, M; Nakajima, T; Xiaoyan, T	1
Gavriatopoulou, M; Kyriazoglou, A; Liontos, M; Ntanasis-Stathopoulos, I	1
Chmielowski, B; Dry, SM; Eilber, FC; Hoffman, RM; Igarashi, K; Kawaguchi, K; Kiyuna, T; Li, Y; Murakami, T; Nelson, SD; Russell, TA; Singh, AS; Unno, M	1
Badalamenti, G; Baldi, A; Casali, P; Collini, P; Dei Tos, AP; Gronchi, A; Iuliani, M; Muda, AO; Pantano, F; Perrone, G; Rabitti, C; Sanfilippo, R; Santini, D; Stacchiotti, S; Tonini, G; Vincenzi, B	1
Embry-Schubert, J; Lentz, SE; Littell, RD; Neugebauer, R; Palen, TE; Raine-Bennett, T; Tucker, LY; Zaritsky, E	1
Inatsu, H; Kitamura, K; Nakashima, K	1
Batte, K; Bid, HK; Braggio, D; Casadei, L; Choy, E; Iwenofu, OH; Koller, D; Lev, D; Lopez, G; Pollock, R; Strohecker, A; Yu, P; Zewdu, A	1
Bouvet, M; Chawla, SP; Endo, I; Higuchi, T; Hiroshima, Y; Hoffman, RM; Kawaguchi, K; Kiyuna, T; Kumamoto, T; Li, Y; Matsuyama, R; Miyake, K; Miyake, M; Murakami, T; Nelson, SD; Oshiro, H; Razmjooei, S; Singh, SR; Wangsiricharoen, S; Zhang, Z	1
Benedetti Panici, P; Tomao, F; Tomao, S	1
Enserro, D; Hensley, ML; Miller, DS	1
Kumar, S; Narain, TA; Sharma, G; Tyagi, S	1
Chae, SH; Chang, M; Choi, AY; Kang, GG; Kim, SN; Lee, SJ; Shim, SH	1
Akagi, Y; Ishikawa, H; Kinugasa, T; Mizobe, T; Ohshima, K; Oka, Y; Setojima, K; Shiratsuchi, I; Shirouzu, K	1
Kok, VC; Li, MC; Ruan, CW; Tsai, HJ	1
Ichioka, D; Kawai, K; Kimura, T; Miyazaki, J; Nagata, C; Nagumo, Y; Nishiyama, H; Oikawa, T; Suetomi, T; Uchida, M	1
Celano, P; Eisenhauer, E; Fader, AN; Frasure, H; Gehrig, PA; Giuntoli, RL; Havrilesky, LJ; Krill, L; Levinson, K; Lopez, MA; Ricci, S; Secord, AA; Tanner, EJ	1
Ito, K; Kaiho-Sakuma, M; Kurosawa, H; Nagai, T; Nagase, S; Niikura, H; Otsuki, A; Otsuki, T; Shiga, N; Shigeta, S; Takano, T; Tanaka, S; Tokunaga, H; Toyoshima, M; Tsuji, K; Utsunomiya, H; Yaegashi, N; Yamaguchi, T	1
Guo, H; Liu, Y; Yang, S; Yao, S; Yao, Z; Zhao, Y	1
Hohenberger, P; Kasper, B; Mathew, M; Pink, D; Rauch, G; Reichardt, P; Sommer, M	1
Bakkum-Gamez, JN; Behbakht, K; Hensley, ML; Mannel, RS; Michael, H; Miller, A; O'Malley, DM	1
Grignani, G; Martín-Broto, J; Reichardt, P; Schuler, M	1
Bassa, B; Chinnia, J; Fletcher, H	1
Inatsu, H; Kondo, Y; Murata, T; Nyomura, S; Takahashi, N; Tokunaga, M; Tomita, K	1
Cousin, S; Ducoulombier, A; Kotecki, N; Penel, N	1
Gehrig, PA; Kim, KH; Milam, B; Palisoul, M; Raker, C; Robison, K; Roque, DR; Taylor, KN; Wysham, WZ	1
Hori, K; Ito, K; Miyagi, K; Murakami, J; Nakagawa, M; Okubo, R; Shiomi, M; Tashima, R; Tsuruta, T; Uragami, K; Yoshioka, E	1
Agarwal, N; Agarwal, P; Baisre, A; Goldstein, IM; Hansberry, DR; Kavi, A	1
Hayasaka, T; Honda, T; Imai, N; Kagabu, S; Kin, S; Matsui, T; Nishigori, H; Oishi, T; Otsuki, T; Sato, H; Sato, K; Shimokawa, H; Shoji, T; Sugiyama, T; Takahashi, F; Tando, T; Tokunaga, H; Wagatsuma, S; Watanabe, T; Watanabe, Y; Yaegashi, N; Yamada, H; Yamamoto, H; Yokoyama, Y; Yoshida, Y; Yoshinaga, K	1
Fader, AN; Ricci, S; Stone, RL	1
Fleming, G	1
Blessing, JA; Hensley, ML; Mannel, R; Rose, PG	1
Bloom, C	1
Benekli, M; Buyukberber, S; Coskun, U; Kaya, AO; Ozdemir, M; Ozturk, B; Sahin, G; Tacoy, G; Topal, S; Yaman, E; Yildiz, R	1
Abu-Rustum, N; Aghajanian, CA; Hensley, ML; Ishill, N; Konner, J; Larkin, J; Sabbatini, P; Soslow, R; Spriggs, D; Tew, W	1
Bui-Nguyen, B; Italiano, A; Toulmonde, M	1
Hayashi, T; Kakuta, Y; Nakai, Y; Nakao, A; Nakayama, M; Nonomura, N; Okumi, M; Takayama, H	1
Collins, IM; Thomas, DM	1
Bertucci, F; Cauvin, C; Chetaille, B; Denoux, Y; Guiramand, J; Hilgers, W; Jacquemier, J; Moureau-Zabotto, L; Sarran, A	1
Akinfenwa, PY; Anderson, ML; Creighton, CJ; Kolomeyevskaya, N; Laucirica, R; Lev, DC; Odunsi, K; Savannah, KB; Shan, W; Thomas, DG	1
Eskander, RN; Guo, Y; Hoang, B; Randall, LM; Sakai, T; Zi, X	1
Blay, JY; Bompas, E; Cioffi, A; Collin, F; Cupissol, D; Delcambre, C; Duffaud, F; Floquet, A; Isambert, N; Jimenez, M; Pautier, P; Penel, N; Piperno-Neumann, S; Rey, A	1
Baker, LH; Crowley, JJ; Maki, RG	1
Bahleda, R; Blay, JY; Dieras, V; LoRusso, P; Macaulay, VM; Mery-Mignard, D; Middleton, MR; Protheroe, AS; Sessa, C; Soria, JC; Tolcher, A	1
Araujo, DM; Baker, LH; George, S; Hensley, ML; Maki, RG; Priebat, DA; Soslow, RA; Sutton, G; Wathen, JK	1
Crucitta, E; De Lena, M; Fiore, M; Lorusso, V; Piscitelli, D; Silvestris, N	1
Blessing, JA; Look, KY; Lucci, JA; Rose, PG; Sandler, A	1
Merimsky, O	1
Blanco-Aparicio, C; Carnero, A; Fominaya, J; Leal, JF; Moneo, V; Pequeño, B; Romero, L; Velasco, J	1
Gajewski, BJ; Mayo, MS	1
Bay, JO; Blay, JY; Brain, E; Bui, NB; Cherix, S; Chevreau, C; Cioffi, A; Coindre, JM; Emile, G; Fayette, J; Isambert, N; Kwiatkowski, F; Le Cesne, A; Leyvraz, S; Penel, N; Peyrade, F; Piperno-Neumann, S; Ray-Coquard, I	1
Aragoncillo, P; Casado Herraez, A; Díaz-Rubio García, E; Gómez Díaz, R; Moreno Antón, F; Puente Vázquez, J	1
Furukawa, K; Ito, T; Kitsukawa, S; Noda, K; Saito, M; Samejimai, T	1
Meerum Terwogt, JM; Rodenhuis, S; Schellens, JH; van Boven, HH; van den Heuvel, MM; Veltkamp, SA	1
Gorzalczany, Y; Merimsky, O; Sagi-Eisenberg, R	1
Burks, T; Chaudhary, UB; Curry, N; Sawhney, R	1
Balani, JP; Mohanty, SK; Parwani, AV	1
Bauer, S; Ebeling, P; Eisele, L; Flasshove, M; Moritz, T; Schuett, P; Schuette, J; Seeber, S	1
Abulafia, O; Blessing, JA; Degeest, K; Hensley, ML; Homesley, HD; Rose, PG	1
Ariad, S; Fenig, E; Flusser, G; Inbar, M; Issakov, J; Kollender, Y; Meller, I; Merimsky, O; Neuman, G; Sapir, D; Weil-Ben-Arush, M	1
Benjamin, RS; Burgess, MA; Gandhi, V; Jenkins, J; Papadopolous, N; Patel, SR; Plager, C; Plunkett, W	1
Aghajanian, C; Barakat, R; Geller, G; Hensley, ML; Lovegren, M; Maki, R; Sabbatini, P; Spriggs, DR; Tong, W; Venkatraman, E	1

Reviews

10 review(s) available for gemcitabine and Leiomyosarcoma

Article	Year
Evaluation of the efficacy of systemic therapy for advanced uterine leiomyosarcoma: A systematic review, meta-analysis, and meta-regression analysis. Cancer medicine, 2023, Volume: 12, Issue:13 Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Gemcitabine; Humans; Leiomyosarcoma; Neoplasm Recurrence, Local; Proportional Hazards Models; Uterine Neoplasms	2023
Successful surgical treatment of cardiac metastasis from uterine leiomyosarcoma: A case report and literature review. The journal of obstetrics and gynaecology research, 2020, Volume: 46, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Female; Gemcitabine; Heart Neoplasms; Humans; Hysterectomy; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Uterine Neoplasms	2020
The systemic treatment of uterine leiomyosarcomas: A systematic review. No news is good news? Medicine, 2021, Apr-02, Volume: 100, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Humans; Immunotherapy; Leiomyosarcoma; Molecular Targeted Therapy; Treatment Outcome; Uterine Neoplasms	2021
Effect of adjuvant therapy on the risk of recurrence in early-stage leiomyosarcoma: A meta-analysis. Gynecologic oncology, 2019, Volume: 154, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Leiomyosarcoma; Observational Studies as Topic; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Uterine Neoplasms	2019
[LEIOMYOSARCOMA ARISING FROM OVARIAN VEIN WITH RIGHT HYDRONEPHROSIS: A CASE REPORT]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2015, Volume: 106, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Hydronephrosis; Leiomyosarcoma; Ovarian Neoplasms; Taxoids; Tomography, X-Ray Computed; Vena Cava, Inferior	2015
Gemcitabine-based chemotherapy in sarcomas: A systematic review of published trials. Critical reviews in oncology/hematology, 2016, Volume: 98 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Deoxycytidine; Gemcitabine; Humans; Leiomyosarcoma; Osteosarcoma; Sarcoma	2016
Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecologic oncology, 2017, Volume: 145, Issue:1 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Chemotherapy, Adjuvant; Deoxycytidine; Diagnostic Errors; Dioxoles; Docetaxel; Doxorubicin; Female; Gemcitabine; Humans; Hysterectomy; Indazoles; Laparoscopy; Leiomyoma; Leiomyosarcoma; Morcellation; Neoplasm Staging; Pyrimidines; Sulfonamides; Taxoids; Tetrahydroisoquinolines; Trabectedin; Uterine Myomectomy; Uterine Neoplasms	2017
[Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines]. Bulletin du cancer, 2010, Volume: 97, Issue:6 Topics: Antineoplastic Agents; Dacarbazine; Deoxycytidine; Dioxoles; Docetaxel; Doxorubicin; Gemcitabine; Humans; Ifosfamide; Leiomyosarcoma; Liposarcoma; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tetrahydroisoquinolines; Trabectedin	2010
Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature. BMC cancer, 2011, Jul-29, Volume: 11 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Gemcitabine; Genital Neoplasms, Male; Humans; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Male; Middle Aged; Prostatectomy; Radiotherapy, Adjuvant; Seminal Vesicles; Taxoids; Treatment Outcome	2011
Pleomorphic leiomyosarcoma of the adrenal gland: case report and review of the literature. Urology, 2007, Volume: 70, Issue:3 Topics: Abdominal Pain; Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Leiomyoma; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Middle Aged; Neoplasms, Second Primary; Nephrectomy; Radiotherapy, Adjuvant; Taxoids; Thrombophlebitis; Uterine Neoplasms	2007

Trials

15 trial(s) available for gemcitabine and Leiomyosarcoma

Article	Year
Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, 08-02, Volume: 28, Issue:15 Topics: Deoxycytidine; Furans; Gemcitabine; Humans; Ketones; Leiomyosarcoma; Liposarcoma; Treatment Outcome	2022
A phase II of gemcitabine combined with pazopanib followed by pazopanib maintenance, as second-line treatment in patients with advanced leiomyosarcomas: A unicancer French Sarcoma Group study (LMS03 study). European journal of cancer (Oxford, England : 1990), 2020, Volume: 125 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Pyrimidines; Sulfonamides	2020
Combination of trabectedin and gemcitabine for advanced soft tissue sarcomas: results of a phase I dose escalating trial of the German Interdisciplinary Sarcoma Group (GISG). Marine drugs, 2015, Jan-13, Volume: 13, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Deoxycytidine; Dioxoles; Drug Therapy, Combination; Female; Gemcitabine; Humans; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Sarcoma; Tetrahydroisoquinolines; Thrombocytopenia; Trabectedin; Transaminases	2015
Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Apr-01, Volume: 33, Issue:10 Topics: Adult; Aged; Anemia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Deoxycytidine; Disease-Free Survival; Docetaxel; Double-Blind Method; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Leiomyosarcoma; Middle Aged; Neoplasm Metastasis; Taxoids; Thrombocytopenia; Time Factors; Treatment Outcome; Uterine Neoplasms	2015
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecologic oncology, 2008, Volume: 109, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Humans; Leiomyosarcoma; Middle Aged; Taxoids; Uterine Neoplasms	2008
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study. Gynecologic oncology, 2009, Volume: 112, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Staging; Prospective Studies; Taxoids; Uterine Neoplasms	2009
Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group The oncologist, 2012, Volume: 17, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Female; France; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Leiomyosarcoma; Lenograstim; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Recombinant Proteins; Taxoids; Uterine Neoplasms	2012
Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:3 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Diarrhea; Docetaxel; Doxorubicin; Erlotinib Hydrochloride; Female; Gemcitabine; Humans; Leiomyosarcoma; Male; Melanoma; Middle Aged; Quinazolines; Receptor, IGF Type 1; Skin Neoplasms; Soft Tissue Neoplasms; Taxoids; Treatment Outcome	2013
Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005). Cancer, 2013, Apr-15, Volume: 119, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cohort Studies; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Gemcitabine; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Prospective Studies; Taxoids; Treatment Outcome; Uterine Neoplasms	2013
Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) Study. Gynecologic oncology, 2004, Volume: 92, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Uterine Neoplasms	2004
Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis. International journal of cancer, 2006, Aug-01, Volume: 119, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Diarrhea; Docetaxel; Drug Administration Schedule; Female; Gemcitabine; Humans; Leiomyosarcoma; Male; Middle Aged; Nausea; Neutropenia; Retrospective Studies; Sarcoma; Survival Analysis; Taxoids; Thrombocytopenia; Treatment Outcome	2006
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. Gynecologic oncology, 2008, Volume: 109, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Taxoids; Uterine Neoplasms	2008
Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study. Cancer chemotherapy and pharmacology, 2000, Volume: 45, Issue:2 Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Chondrosarcoma; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Leiomyosarcoma; Male; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome	2000
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Aug-01, Volume: 19, Issue:15 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Neoplasms; Gemcitabine; Humans; Infusions, Intravenous; Leiomyosarcoma; Leukocytes, Mononuclear; Male; Middle Aged; Phosphates; Sarcoma; Soft Tissue Neoplasms	2001
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jun-15, Volume: 20, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leiomyosarcoma; Middle Aged; Neutropenia; Paclitaxel; Taxoids; Thrombocytopenia; Treatment Outcome; Uterine Neoplasms	2002

Other Studies

41 other study(ies) available for gemcitabine and Leiomyosarcoma

Article	Year
Efficacy of Eribulin Plus Gemcitabine Combination in L-Sarcomas. International journal of molecular sciences, 2022, Dec-30, Volume: 24, Issue:1 Topics: Furans; Gemcitabine; Humans; Ketones; Leiomyosarcoma; Sarcoma; Soft Tissue Neoplasms	2022
Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma. Gynecologic oncology, 2020, Volume: 157, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cohort Studies; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Japan; L-Lactate Dehydrogenase; Leiomyosarcoma; Middle Aged; Neoplasm Staging; Prognosis; Progression-Free Survival; Retrospective Studies; Uterine Neoplasms; Young Adult	2020
Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model. Cell cycle (Georgetown, Tex.), 2017, Jun-03, Volume: 16, Issue:11 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cell Proliferation; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Imaging, Three-Dimensional; Leiomyosarcoma; Luminescent Proteins; Mice, Nude; Mice, Transgenic; Neoplasm Invasiveness; Red Fluorescent Protein; Stomach Neoplasms; Taxoids; Tumor Burden; Xenograft Model Antitumor Assays	2017
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma. British journal of cancer, 2017, Jul-25, Volume: 117, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Disease-Free Survival; Equilibrative Nucleoside Transporter 1; Female; Gemcitabine; Gene Expression; Hemangiosarcoma; Humans; Kaplan-Meier Estimate; Leiomyosarcoma; Male; Middle Aged; Retrospective Studies; Survival Rate	2017
Adjuvant gemcitabine-docetaxel chemotherapy for stage I uterine leiomyosarcoma: Trends and survival outcomes. Gynecologic oncology, 2017, Volume: 147, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Retrospective Studies; Taxoids; Uterine Neoplasms	2017
Primary Cardiac Leiomyosarcoma: A 27-Month Survival with Surgery and Chemotherapy. Internal medicine (Tokyo, Japan), 2017, Aug-15, Volume: 56, Issue:16 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Deoxycytidine; Docetaxel; Doxorubicin; Fatal Outcome; Gemcitabine; Heart Neoplasms; Humans; Ifosfamide; Indoles; Leiomyosarcoma; Life Support Care; Male; Mesna; Pyrroles; Sunitinib; Taxoids	2017
Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates. PloS one, 2017, Volume: 12, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Cell Division; Cell Line, Tumor; Deoxycytidine; Drug Synergism; Gemcitabine; Humans; Leiomyosarcoma; Pyrimidines	2017
Gemcitabine combined with docetaxel precisely regressed a recurrent leiomyosarcoma peritoneal metastasis in a patient-derived orthotopic xenograft (PDOX) model. Biochemical and biophysical research communications, 2019, 02-19, Volume: 509, Issue:4 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Gemcitabine; Heterografts; Humans; Leiomyosarcoma; Mice; Mice, Nude; Neoplasm Metastasis; Peritoneal Neoplasms; Recurrence; Salvage Therapy; Treatment Outcome; Tumor Burden	2019
Adjuvant Therapy for Early Uterine High-Grade Leiomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 04-10, Volume: 37, Issue:11 Topics: Deoxycytidine; Docetaxel; Doxorubicin; Female; Gemcitabine; Humans; Leiomyosarcoma; Uterine Neoplasms	2019
Reply to F. Tomao et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 04-10, Volume: 37, Issue:11 Topics: Deoxycytidine; Docetaxel; Doxorubicin; Female; Gemcitabine; Humans; Leiomyosarcoma	2019
Bilateral leiomyosarcoma of kidneys with pericardial metastases: a double whammy. BMJ case reports, 2019, Mar-20, Volume: 12, Issue:3 Topics: Administration, Intravenous; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Deoxycytidine; Docetaxel; Fatal Outcome; Gemcitabine; Heart Neoplasms; Humans; Kidney Neoplasms; Leiomyosarcoma; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography	2019
Gemcitabine with paclitaxel therapy against mesocolic leiomyosarcoma: a case report. Anticancer research, 2013, Volume: 33, Issue:7 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Humans; Leiomyosarcoma; Male; Mesocolon; Neoplasm Recurrence, Local; Paclitaxel; Prognosis	2013
A large primary vaginal leiomyosarcoma diagnosed postoperatively and uterine leiomyomas treated with surgery and chemotherapy. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2013, Volume: 33, Issue:6 Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Leiomyoma; Leiomyosarcoma; Middle Aged; Taxoids; Uterine Neoplasms; Vagina; Vaginal Neoplasms	2013
[Long-term survival with gemcitabine and docetaxel for renal leiomyosarcoma : a case report]. Hinyokika kiyo. Acta urologica Japonica, 2013, Volume: 59, Issue:8 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Kidney Neoplasms; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Pancreatic Neoplasms; Taxoids	2013
Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma? Gynecologic oncology, 2013, Volume: 131, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Retrospective Studies; Taxoids; Uterine Neoplasms	2013
Feasibility study of gemcitabine plus docetaxel in advanced or recurrent uterine leiomyosarcoma and undifferentiated endometrial sarcoma in Japan. International journal of clinical oncology, 2014, Volume: 19, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Feasibility Studies; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Japan; Leiomyosarcoma; Middle Aged; Sarcoma, Endometrial Stromal; Taxoids; Uterine Neoplasms	2014
[Efficacy and safety of fixed dose rate gemcitabine infusion in combination with docetaxel in patients with relapsed/refractory soft tissue sarcoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2014, Volume: 36, Issue:7 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Docetaxel; Gemcitabine; Humans; Leiomyosarcoma; Neoplasm Recurrence, Local; Neutropenia; Retrospective Studies; Sarcoma; Taxoids; Treatment Outcome	2014
Trabectedin clinical cases: use according to indication in diverse clinical scenarios. Future oncology (London, England), 2015, Volume: 11, Issue:11 Suppl Topics: Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Contraindications; Dacarbazine; Deoxycytidine; Dioxoles; Female; Femoral Neoplasms; Gemcitabine; Humans; Hysterectomy; Ifosfamide; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Neoadjuvant Therapy; Radionuclide Imaging; Remission Induction; Salvage Therapy; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Thigh; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome; Uterine Neoplasms	2015
Leiomyosarcoma of the vagina in pregnancy. European journal of gynaecological oncology, 2015, Volume: 36, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Cyclophosphamide; Delayed Diagnosis; Deoxycytidine; Doxorubicin; Fatal Outcome; Female; Gemcitabine; Humans; Leiomyosarcoma; Pregnancy; Pregnancy Complications, Neoplastic; Vaginal Neoplasms; Vincristine	2015
Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine Leiomyosarcoma. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2016, Volume: 26, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Female; Follow-Up Studies; Gemcitabine; Humans; Leiomyosarcoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Taxoids; Uterine Neoplasms	2016
[A Case of Bilateral Pneumothorax after Chemotherapy for Uterine Leiomyosarcoma with Multiple Lung Metastases]. Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Hysterectomy; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Ovariectomy; Pneumothorax; Taxoids	2016
Prognostic Differences: Epstein-Barr Virus-Associated Primary Leiomyosarcoma of the Spine Versus Spinal Leiomyosarcoma Metastases. World neurosurgery, 2017, Volume: 99 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Deoxycytidine; Docetaxel; Epstein-Barr Virus Infections; Female; Gemcitabine; Herpesvirus 4, Human; Humans; Immunocompromised Host; Leiomyosarcoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Prognosis; Retroperitoneal Neoplasms; Spinal Neoplasms; Taxoids	2017
Current Status of Uterine Leiomyosarcoma in the Tohoku Region: Results of the Tohoku Translational Center Development Network Survey. International journal of clinical oncology, 2017, Volume: 22, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Docetaxel; Female; Gemcitabine; Health Surveys; Humans; Japan; Leiomyosarcoma; Lymph Node Excision; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Taxoids; Uterine Neoplasms	2017
Gemcitabine/docetaxel--welcome to a new standard. Gynecologic oncology, 2008, Volume: 109, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Leiomyosarcoma; Taxoids; Uterine Neoplasms	2008
Breathless beyond obvious. BMJ (Clinical research ed.), 2008, Sep-17, Volume: 337 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Diagnosis, Differential; Docetaxel; Dyspnea; Endometrial Neoplasms; Female; Gemcitabine; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Taxoids	2008
Gemcitabine-induced acute coronary syndrome: a case report. Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2009, Volume: 18, Issue:1 Topics: Antimetabolites, Antineoplastic; Aspirin; Bundle-Branch Block; Clopidogrel; Coronary Artery Disease; Coronary Vasospasm; Deoxycytidine; Electrocardiography; Fatal Outcome; Female; Gemcitabine; Humans; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine	2009
[A case of leiomyosarcoma of prostate: multimodality therapy suppressed disease progression for long term]. Hinyokika kiyo. Acta urologica Japonica, 2010, Volume: 56, Issue:9 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Leiomyosarcoma; Male; Prostatic Neoplasms; Taxoids	2010
Novel approaches to treatment of leiomyosarcomas. Current oncology reports, 2011, Volume: 13, Issue:4 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Doxorubicin; Enzyme Inhibitors; Gemcitabine; Humans; Ifosfamide; Leiomyosarcoma; Molecular Targeted Therapy; Neoplasm Metastasis; Poly(ADP-ribose) Polymerase Inhibitors; Taxoids	2011
A small-molecule inhibitor targeting the mitotic spindle checkpoint impairs the growth of uterine leiomyosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Jun-15, Volume: 18, Issue:12 Topics: Animals; Apoptosis; Aurora Kinase A; Aurora Kinases; Cell Line, Tumor; Cell Proliferation; Centrosome; Cyclohexanecarboxylic Acids; Deoxycytidine; Docetaxel; Female; Gemcitabine; Gene Expression Profiling; Humans; Leiomyoma; Leiomyosarcoma; M Phase Cell Cycle Checkpoints; Mice; Mice, Nude; Myometrium; Protein Serine-Threonine Kinases; RNA Interference; RNA, Small Interfering; Taxoids; Thiazoles; Uterine Neoplasms; Xenograft Model Antitumor Assays	2012
Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell line. The journal of obstetrics and gynaecology research, 2012, Volume: 38, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Deoxycytidine; Docetaxel; Drug Evaluation, Preclinical; Drug Synergism; Female; Fibroblasts; Flavonoids; G2 Phase Cell Cycle Checkpoints; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Leiomyosarcoma; Phytotherapy; Plant Extracts; Survivin; Taxoids; Uterine Neoplasms	2012
Randomization and statistical power: paramount in trial reproducibility (even for rare cancers). The oncologist, 2012, Volume: 17, Issue:9 Topics: Deoxycytidine; Docetaxel; Female; Gemcitabine; Humans; Leiomyosarcoma; Male; Taxoids	2012
Unusual response to second-line single-agent gemcitabine in locally advanced primary leiomyosarcoma of the lung: a case report. Journal of chemotherapy (Florence, Italy), 2003, Volume: 15, Issue:5 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Epirubicin; Gemcitabine; Humans; Ifosfamide; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged	2003
Targeting metastatic leiomyosarcoma by rapamycin plus gemcitabine: an intriguing clinical observation. International journal of molecular medicine, 2004, Volume: 14, Issue:5 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Diabetic Nephropathies; Gemcitabine; Humans; Kidney Failure, Chronic; Kidney Neoplasms; Kidney Transplantation; Leiomyosarcoma; Liver Neoplasms; Male; Middle Aged; Sirolimus; Tomography, X-Ray Computed; Treatment Outcome	2004
Inhibition of phosphatidylinositol-3-kinase synergizes with gemcitabine in low-passage tumor cell lines correlating with Bax translocation to the mitochondria. Anti-cancer drugs, 2005, Volume: 16, Issue:9 Topics: bcl-2-Associated X Protein; bcl-X Protein; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromones; Deoxycytidine; DNA-Binding Proteins; Enzyme Inhibitors; Female; Gemcitabine; Gene Expression; Genes, Tumor Suppressor; Humans; Inhibitory Concentration 50; Leiomyosarcoma; Melanoma; Mitochondria; Morpholines; Neoplasms; Nuclear Proteins; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2005
Bayesian sample size calculations in phase II clinical trials using a mixture of informative priors. Statistics in medicine, 2006, Aug-15, Volume: 25, Issue:15 Topics: Algorithms; Antineoplastic Agents; Bayes Theorem; Clinical Trials, Phase II as Topic; Computer Simulation; Deoxycytidine; Docetaxel; Gemcitabine; Head and Neck Neoplasms; Humans; Leiomyosarcoma; Organoplatinum Compounds; Oxaliplatin; Sample Size; Taxoids	2006
Cardiac metastasis from uterine leiomyosarcoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Deoxycytidine; Diagnostic Errors; Docetaxel; Doxorubicin; Fatal Outcome; Female; Gemcitabine; Heart Neoplasms; Humans; Hysterectomy; Ifosfamide; Kidney Neoplasms; Leiomyoma; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Ovariectomy; Taxoids; Temozolomide; Thoracic Surgery, Video-Assisted; Uterine Neoplasms	2006
[A case of leiomyosarcoma of the scrotum: chemotherapy with anti-cancer agents was effective for the lung metastasis]. Hinyokika kiyo. Acta urologica Japonica, 2006, Volume: 52, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Genital Neoplasms, Male; Humans; Leiomyosarcoma; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pneumonectomy; Scrotum	2006
Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel. Investigational new drugs, 2007, Volume: 25, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arm; Deoxycytidine; Docetaxel; Fatal Outcome; Female; Gemcitabine; Humans; Leiomyosarcoma; Middle Aged; Ovarian Neoplasms; Respiratory Distress Syndrome; Severity of Illness Index; Taxoids; Tomography, X-Ray Computed; Treatment Outcome	2007
Molecular impacts of rapamycin-based drug combinations: combining rapamycin with gemcitabine or imatinib mesylate (Gleevec) in a human leiomyosarcoma model. International journal of oncology, 2007, Volume: 31, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Humans; Imatinib Mesylate; Leiomyosarcoma; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Piperazines; Pyrimidines; Signal Transduction; Sirolimus	2007
Locally advanced leiomyosarcoma of the urinary bladder: near-complete pathologic response to neoadjuvant gemcitabine and docetaxel. Anti-cancer drugs, 2007, Volume: 18, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Docetaxel; Gemcitabine; Humans; Leiomyosarcoma; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Taxoids; Urinary Bladder Neoplasms	2007
Docetaxel and gemcitabine in the treatment of soft tissue sarcoma - a single-center experience. Onkologie, 2008, Volume: 31, Issue:1-2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gemcitabine; Humans; Leiomyosarcoma; Male; Middle Aged; Neoplasm Staging; Palliative Care; Retrospective Studies; Sarcoma; Survival Analysis; Taxoids; Uterine Neoplasms	2008